Revance Therapeutics, Inc. (RVNC)
NASDAQ: RVNC · IEX Real-Time Price · USD
3.580
+0.310 (9.48%)
At close: Jul 12, 2024, 4:00 PM
3.600
+0.020 (0.56%)
After-hours: Jul 12, 2024, 7:59 PM EDT

Revance Therapeutics Market Cap

Revance Therapeutics has a market cap or net worth of $373.92 million as of July 12, 2024. Its market cap has decreased by -81.50% in one year.

Market Cap
373.92M
Enterprise Value
572.08M
1-Year Change
-81.50%
Ranking
Category
Stock Price
$3.58

Market Cap Chart

Since February 6, 2014, Revance Therapeutics's market cap has decreased from $453.20M to $373.92M, a decrease of -17.49%. That is a compound annual growth rate of -1.83%.

History

DateMarket Cap% Change
Jul 12, 2024373.90M-51.56%
Dec 29, 2023771.90M-49.18%
Dec 30, 20221.52B29.62%
Dec 31, 20211.17B-37.87%
Dec 31, 20201.89B157.62%
Dec 31, 2019732.10M-1.68%
Dec 31, 2018744.60M-32.67%
Dec 29, 20171.11B87.35%
Dec 30, 2016590.30M-38.42%
Dec 31, 2015958.60M138.58%
Dec 31, 2014401.80M-11.34%
Feb 6, 2014453.20M-
View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Tourmaline Bio 382.39M
Health Catalyst 381.96M
Cartesian Therapeutics 379.27M
Sight Sciences 378.65M
Alto Neuroscience 375.30M
ALX Oncology Holdings 367.83M
ADC Therapeutics 367.58M
Talkspace 363.13M
Market Cap Rankings